Open Access
Open access
volume 383 issue 9911 pages 69-82

Type 1 diabetes

Mark Atkinson 1
George S. Eisenbarth 2
Aaron W. Michels 2
Publication typeJournal Article
Publication date2014-01-01
scimago Q1
wos Q1
SJR12.113
CiteScore87.6
Impact factor88.5
ISSN01406736, 1474547X
General Medicine
Abstract
Over the past decade, knowledge of the pathogenesis and natural history of type 1 diabetes has grown substantially, particularly with regard to disease prediction and heterogeneity, pancreatic pathology, and epidemiology. Technological improvements in insulin pumps and continuous glucose monitors help patients with type 1 diabetes manage the challenge of lifelong insulin administration. Agents that show promise for averting debilitating disease-associated complications have also been identified. However, despite broad organisational, intellectual, and fiscal investments, no means for preventing or curing type 1 diabetes exists, and, globally, the quality of diabetes management remains uneven. This Seminar discusses current progress in epidemiology, pathology, diagnosis, and treatment of type 1 diabetes, and prospects for an improved future for individuals with this disease.
Found 
Found 

Top-30

Journals

5
10
15
20
25
30
35
40
45
50
Frontiers in Endocrinology
49 publications, 2.46%
Frontiers in Immunology
49 publications, 2.46%
Diabetologia
46 publications, 2.31%
Diabetes
37 publications, 1.86%
Scientific Reports
29 publications, 1.46%
International Journal of Molecular Sciences
26 publications, 1.31%
PLoS ONE
25 publications, 1.26%
Pediatric Diabetes
25 publications, 1.26%
Nutrients
24 publications, 1.21%
Current Diabetes Reports
20 publications, 1%
Diabetes Care
20 publications, 1%
BMJ Open
16 publications, 0.8%
Journal of Clinical Endocrinology and Metabolism
14 publications, 0.7%
Diabetes Research and Clinical Practice
14 publications, 0.7%
Acta Diabetologica
13 publications, 0.65%
Journal of Autoimmunity
13 publications, 0.65%
Journal of Clinical Medicine
12 publications, 0.6%
Nature Communications
12 publications, 0.6%
Diabetes/Metabolism Research and Reviews
12 publications, 0.6%
Cells
11 publications, 0.55%
Diabetic Medicine
11 publications, 0.55%
Current Opinion in Endocrinology, Diabetes and Obesity
10 publications, 0.5%
Biomolecules
10 publications, 0.5%
Biomedicine and Pharmacotherapy
10 publications, 0.5%
Clinical Immunology
10 publications, 0.5%
Journal of Diabetes Investigation
10 publications, 0.5%
Diabetes, Obesity and Metabolism
10 publications, 0.5%
Advances in Experimental Medicine and Biology
10 publications, 0.5%
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
10 publications, 0.5%
5
10
15
20
25
30
35
40
45
50

Publishers

50
100
150
200
250
300
350
400
Elsevier
387 publications, 19.44%
Springer Nature
355 publications, 17.83%
Wiley
195 publications, 9.79%
MDPI
158 publications, 7.94%
Frontiers Media S.A.
130 publications, 6.53%
Taylor & Francis
71 publications, 3.57%
American Diabetes Association
58 publications, 2.91%
Cold Spring Harbor Laboratory
50 publications, 2.51%
Ovid Technologies (Wolters Kluwer Health)
32 publications, 1.61%
Hindawi Limited
30 publications, 1.51%
SAGE
29 publications, 1.46%
The Endocrine Society
28 publications, 1.41%
American Chemical Society (ACS)
28 publications, 1.41%
Institute of Electrical and Electronics Engineers (IEEE)
28 publications, 1.41%
Public Library of Science (PLoS)
27 publications, 1.36%
BMJ
27 publications, 1.36%
Oxford University Press
22 publications, 1.1%
Bentham Science Publishers Ltd.
19 publications, 0.95%
American Society for Clinical Investigation
15 publications, 0.75%
Mary Ann Liebert
12 publications, 0.6%
JMIR Publications
10 publications, 0.5%
Georg Thieme Verlag KG
9 publications, 0.45%
Baishideng Publishing Group
9 publications, 0.45%
Walter de Gruyter
9 publications, 0.45%
Royal Society of Chemistry (RSC)
8 publications, 0.4%
American Association for the Advancement of Science (AAAS)
8 publications, 0.4%
Spandidos Publications
7 publications, 0.35%
The American Association of Immunologists
7 publications, 0.35%
S. Karger AG
7 publications, 0.35%
50
100
150
200
250
300
350
400
  • We do not take into account publications without a DOI.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
2k
Share
Cite this
GOST |
Cite this
GOST Copy
Atkinson M., Eisenbarth G. S., Michels A. W. Type 1 diabetes // The Lancet. 2014. Vol. 383. No. 9911. pp. 69-82.
GOST all authors (up to 50) Copy
Atkinson M., Eisenbarth G. S., Michels A. W. Type 1 diabetes // The Lancet. 2014. Vol. 383. No. 9911. pp. 69-82.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1016/S0140-6736(13)60591-7
UR - https://doi.org/10.1016/S0140-6736(13)60591-7
TI - Type 1 diabetes
T2 - The Lancet
AU - Atkinson, Mark
AU - Eisenbarth, George S.
AU - Michels, Aaron W.
PY - 2014
DA - 2014/01/01
PB - Elsevier
SP - 69-82
IS - 9911
VL - 383
PMID - 23890997
SN - 0140-6736
SN - 1474-547X
ER -
BibTex |
Cite this
BibTex (up to 50 authors) Copy
@article{2014_Atkinson,
author = {Mark Atkinson and George S. Eisenbarth and Aaron W. Michels},
title = {Type 1 diabetes},
journal = {The Lancet},
year = {2014},
volume = {383},
publisher = {Elsevier},
month = {jan},
url = {https://doi.org/10.1016/S0140-6736(13)60591-7},
number = {9911},
pages = {69--82},
doi = {10.1016/S0140-6736(13)60591-7}
}
MLA
Cite this
MLA Copy
Atkinson, Mark, et al. “Type 1 diabetes.” The Lancet, vol. 383, no. 9911, Jan. 2014, pp. 69-82. https://doi.org/10.1016/S0140-6736(13)60591-7.